Long non-coding RNAs in biomarking COVID-19: a machine learning-based approach

Chilamakuri R, Agarwal S. COVID-19: characteristics and therapeutics. Cells. 2021;10(2):206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med. 2022;54(1):524–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Putra HP, Arimaswati AHS, Karya ID. Analysis of risk factors for death in COVID-19 patients at Bahteramas Regional General Hospital, Southeast Sulawesi Province. Hypertension. 24(28):2.

Triggle CR, Bansal D, Ding H, Islam MM, Farag EABA, Hadi HA, Sultan AA. A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic. Front Immunol. 2021;12:631139.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodrigues R, Costa de Oliveira S. The impact of angiotensin-converting enzyme 2 (ACE2) expression levels in patients with comorbidities on COVID-19 severity: a comprehensive review. Microorganisms. 2021;9(8):1692.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jalaleddine N, Bouzid A, Hachim M, Sharif-Askari NS, Mahboub B, Senok A, et al. ACE2 polymorphisms impact COVID-19 severity in obese patients. Sci Rep. 2022;12(1):21491.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakhshandeh B, Sorboni SG, Javanmard A-R, Mottaghi SS, Mehrabi M-r, Sorouri F, et al. Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect Genet Evol. 2021;90:104773.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alsharif W, Qurashi A. Effectiveness of COVID-19 diagnosis and management tools: a review. Radiography. 2021;27(2):682–7.

Article  CAS  PubMed  Google Scholar 

Mi S, Zhang J, Zhang W, Huang RS. Circulating microRNAs as biomarkers for inflammatory diseases. Microrna. 2013;2(1):64–72.

Article  CAS  PubMed Central  Google Scholar 

Maranini B, Ciancio G, Ferracin M, Cultrera R, Negrini M, Sabbioni S, Govoni M. microRNAs and inflammatory immune response in SARS-CoV-2 infection: a narrative review. Life. 2022;12(2):288.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Li J, Zhang L, Sun H-X, Zhang Z, Xu J, et al. Plasma cell-free RNA characteristics in COVID-19 patients. Genome Res. 2022;32(2):228–41.

Article  PubMed  PubMed Central  Google Scholar 

Vishnubalaji R, Shaath H, Alajez NM. Protein coding and long noncoding RNA (lncRNA) transcriptional landscape in SARS-CoV-2 infected bronchial epithelial cells highlight a role for interferon and inflammatory response. Genes. 2020;11(7):760.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jalaleddine N, Gaudet M, Mogas A, Hachim M, Senok A, Sharif-Askari NS, et al. Cell free ACE2 RNA: a potential biomarker of COVID-19 severity. Respir Med. 2023;219:107409.

Article  PubMed  Google Scholar 

Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2):e202009045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xing C, Sun S-g, Yue Z-Q, Bai F. Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother. 2021;134:111158.

Article  CAS  PubMed  Google Scholar 

Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118.

Article  CAS  PubMed  Google Scholar 

Wang W, Yang N, Wen R, Liu C-F, Zhang T-N. Long noncoding RNA: regulatory mechanisms and therapeutic potential in sepsis. Front Cell Infect Microbiol. 2021;11:563126.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Zhao T, Deng R, Xia X, Li B, Wang X. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood. Sci Rep. 2021;11(1):7991.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Xuan Z, Zhou S, Kuang L, Pei T. A novel model for predicting LncRNA-disease associations based on the LncRNA-MiRNA-disease interactive network. Curr Bioinform. 2019;14(3):269–78.

Article  CAS  Google Scholar 

Sefatjoo Z, Mohebbi SR, Hosseini SM, Shoraka S, Niasar MS, Baghaei K, et al. Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients. Cytokine. 2024;175:156495.

Article  CAS  PubMed  Google Scholar 

Tayel SI, El-Masry EA, Abdelaal GA, Shehab-Eldeen S, Essa A, Muharram NM. Interplay of LncRNAs NEAT1 and TUG1 in incidence of cytokine storm in appraisal of COVID-19 infection. Int J Biol Sci. 2022;18(13):4901.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo C, Qi Y, Qu J, Gai L, Shi Y, Yuan C. Pathophysiological functions of the lncRNA TUG1. Curr Pharm Design. 2020;26(6):688–700.

Article  CAS  Google Scholar 

Xue M, Xia F, Wang Y, Zhu L, Li Y, Jia D, et al. The role of LncRNA TUG1 in obesity-related diseases. Mini Rev Med Chem. 2022;22(9):1305–13.

Article  CAS  PubMed  Google Scholar 

Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. Int J Biochem Cell Biol. 2018;101:19–28.

Article  CAS  PubMed  Google Scholar 

Tang W, Shen Z, Guo J, Sun S. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD. Int J Chronic Obstr Pulm Dis. 2016:2951–64.

Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10(1):1–17.

Article  Google Scholar 

Bitarafan S, Yari M, Broumand MA, Ghaderian SMH, Rahimi M, Mirfakhraie R, et al. Association of increased levels of lncRNA H19 in PBMCs with risk of coronary artery disease. Cell J (Yakhteh). 2019;20(4):564.

Google Scholar 

Yao Y, Xiong G, Jiang X, Song T. The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease. Revista Da Associação Médica Brasileira. 2019;65:110–7.

Article  Google Scholar 

Pope C, Mishra S, Russell J, Zhou Q, Zhong X-B. Targeting H19, an imprinted long non-coding RNA, in hepatic functions and liver diseases. Diseases. 2017;5(1):11.

Article  PubMed  PubMed Central  Google Scholar 

Wang B, Suen CW, Ma H, Wang Y, Kong L, Qin D, et al. The roles of H19 in regulating inflammation and aging. Front Immunol. 2020;11:579687.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Z, Zhang T, Han S, Kusumanchi P, Huda N, Jiang Y, Liangpunsakul S. Long noncoding RNA H19–a new player in the pathogenesis of liver diseases. Translational Res. 2021;230:139–50.

Article  CAS  Google Scholar 

Chen M-J, Deng J, Chen C, Hu W, Yuan Y-C, Xia Z-K. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis. Int J Biochem Cell Biol. 2019;113:27–36.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif